200 related articles for article (PubMed ID: 30347240)
1. 2B4 (CD244, SLAMF4) and CS1 (CD319, SLAMF7) in systemic lupus erythematosus and cancer.
Malaer JD; Marrufo AM; Mathew PA
Clin Immunol; 2019 Jul; 204():50-56. PubMed ID: 30347240
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of signalling lymphocyte activation molecule (SLAM) family receptors CS1 (CD319) and 2B4 (CD244) in patients with systemic lupus erythematosus.
Kim JR; Mathew SO; Patel RK; Pertusi RM; Mathew PA
Clin Exp Immunol; 2010 Jun; 160(3):348-58. PubMed ID: 20345977
[TBL] [Abstract][Full Text] [Related]
3. Roles of NK Cell Receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in Cancer.
Buller CW; Mathew PA; Mathew SO
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630303
[TBL] [Abstract][Full Text] [Related]
4. CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.
Malaer JD; Mathew PA
Am J Cancer Res; 2017; 7(8):1637-1641. PubMed ID: 28861320
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic cells and CD319 on CD56(dim) NK cells.
Hagberg N; Theorell J; Schlums H; Eloranta ML; Bryceson YT; Rönnblom L
J Immunol; 2013 Sep; 191(6):2989-98. PubMed ID: 23956418
[TBL] [Abstract][Full Text] [Related]
6. Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4-Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus.
Kis-Toth K; Comte D; Karampetsou MP; Kyttaris VC; Kannan L; Terhorst C; Tsokos GC
Arthritis Rheumatol; 2016 Jan; 68(1):164-73. PubMed ID: 26314831
[TBL] [Abstract][Full Text] [Related]
7. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.
Sayós J; Nguyen KB; Wu C; Stepp SE; Howie D; Schatzle JD; Kumar V; Biron CA; Terhorst C
Int Immunol; 2000 Dec; 12(12):1749-57. PubMed ID: 11099315
[TBL] [Abstract][Full Text] [Related]
8. 2B4 (CD244), NTB-A and CRACC (CS1) stimulate cytotoxicity but no proliferation in human NK cells.
Stark S; Watzl C
Int Immunol; 2006 Feb; 18(2):241-7. PubMed ID: 16410313
[TBL] [Abstract][Full Text] [Related]
9. Brief report: Decreased expression of CD244 (SLAMF4) on monocytes and platelets in patients with systemic lupus erythematosus.
Mak A; Thornhill SI; Lee HY; Lee B; Poidinger M; Connolly JE; Fairhurst AM
Clin Rheumatol; 2018 Mar; 37(3):811-816. PubMed ID: 28593610
[TBL] [Abstract][Full Text] [Related]
10. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
Tangye SG; Phillips JH; Lanier LL; Nichols KE
J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
[TBL] [Abstract][Full Text] [Related]
11. 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes.
Boles KS; Stepp SE; Bennett M; Kumar V; Mathew PA
Immunol Rev; 2001 Jun; 181():234-49. PubMed ID: 11513145
[TBL] [Abstract][Full Text] [Related]
12. CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma.
Veillette A; Guo H
Crit Rev Oncol Hematol; 2013 Oct; 88(1):168-77. PubMed ID: 23731618
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients.
Meazza R; Falco M; Marcenaro S; Loiacono F; Canevali P; Bellora F; Tuberosa C; Locatelli F; Micalizzi C; Moretta A; Mingari MC; Moretta L; Aricò M; Bottino C; Pende D
Eur J Immunol; 2017 Jun; 47(6):1051-1061. PubMed ID: 28386908
[TBL] [Abstract][Full Text] [Related]
14. Chicken SLAMF4 (CD244, 2B4), a receptor expressed on thrombocytes, monocytes, NK cells, and subsets of αβ-, γδ- T cells and B cells binds to SLAMF2.
Straub C; Neulen ML; Viertlboeck BC; Göbel TW
Dev Comp Immunol; 2014 Feb; 42(2):159-68. PubMed ID: 24055739
[TBL] [Abstract][Full Text] [Related]
15. 2B4 and CD48: A powerful couple of the immune system.
Pahima H; Puzzovio PG; Levi-Schaffer F
Clin Immunol; 2019 Jul; 204():64-68. PubMed ID: 30366105
[TBL] [Abstract][Full Text] [Related]
16. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
[TBL] [Abstract][Full Text] [Related]
17. Advances in Understanding the Roles of CD244 (SLAMF4) in Immune Regulation and Associated Diseases.
Sun L; Gang X; Li Z; Zhao X; Zhou T; Zhang S; Wang G
Front Immunol; 2021; 12():648182. PubMed ID: 33841431
[TBL] [Abstract][Full Text] [Related]
18. Evolving role of 2B4/CD244 in T and NK cell responses during virus infection.
Waggoner SN; Kumar V
Front Immunol; 2012; 3():377. PubMed ID: 23248626
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).
Romero X; Benítez D; March S; Vilella R; Miralpeix M; Engel P
Tissue Antigens; 2004 Aug; 64(2):132-44. PubMed ID: 15245368
[TBL] [Abstract][Full Text] [Related]
20. NK cell regulation by SLAM family receptors and SAP-related adapters.
Veillette A
Immunol Rev; 2006 Dec; 214():22-34. PubMed ID: 17100873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
